← Leaderboards
Sarah L. Kerns
University Of Rochester
$1,745,658
Attributed
$3,387,947
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2015–25$2M$1.5M$1M$500K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,387,947 · 4
By mechanism
R01$2,323,831 · 2
K07$649,335 · 1
R21$414,781 · 1
Top collaborators
- Brian Marples3 shared
- William Hall2 shared
- Jung Hun Oh2 shared
- Steven R. Gill1 shared
Most similar at University Of Rochester
Same institution · by research overlap
- Catherine Ovitt$9,674,992
- Danielle S. Benoit$10,277,461
- Lisa A. Delouise$6,904,175
- Yuhchyau Chen$4,833,616
- Bruce M Fenton$3,373,812
Others in their field
Top investigators on “Genome Wide Association Study”
- David Heimbrook · Leidos Biomedical Research, Inc.$111,485,565
- James D Crapo · University Of Colorado Denver$80,593,932
- David A Bennett · Rush University Medical Center$78,184,796
- Michael A Province · Washington University$77,809,700
- Li-San Wang · University Of Pennsylvania$67,433,768
- Gerard David Schellenberg · University Of California San Diego$65,975,701
Research focus
Genome Wide Association StudyCohortMalignant Neoplasm Of ProstateDoseCancer PatientToxic EffectPathway InteractionsRadiation TherapyNormal Tissue MorphologyBiologicalTreatment-Related ToxicityDiagnosisTreatment PlanningUrinaryQuality Of LifeProspectiveRadiation ToxicityRadiationAffectOperative Surgical ProceduresGeneticHypertensionCancer TherapyData Set
Grant awards (10)
Multi-cohort validation of machine learning radiogenomic models (ML-RGx) to predict late toxicity in prostate cancer$633,691
R01 · FY2025 · CA · contact PI
Targeting angiotensin and inflammation to prevent radiotherapy-induced bladder toxicity.$550,549
R01 · FY2025 · CA
Multi-cohort validation of machine learning radiogenomic models (ML-RGx) to predict late toxicity in prostate cancer$589,425
R01 · FY2024 · CA · contact PI
Targeting angiotensin and inflammation to prevent radiotherapy-induced bladder toxicity.$550,166
R01 · FY2024 · CA
The urinary microbiome and bladder toxicity after pelvic radiotherapy$414,781
R21 · FY2024 · CA
Risk Prediction for Development of Adverse Effects FOllowing Radiotherapy for Prostate Cancer$129,867
K07 · FY2019 · CA · contact PI
Risk Prediction for Development of Adverse Effects FOllowing Radiotherapy for Prostate Cancer$129,867
K07 · FY2018 · CA · contact PI
Risk Prediction for Development of Adverse Effects FOllowing Radiotherapy for Prostate Cancer$129,867
K07 · FY2017 · CA · contact PI
Risk Prediction for Development of Adverse Effects FOllowing Radiotherapy for Prostate Cancer$129,867
K07 · FY2016 · CA · contact PI
Risk Prediction for Development of Adverse Effects FOllowing Radiotherapy for Prostate Cancer$129,867
K07 · FY2015 · CA · contact PI